| Document And Entity Information - USD ($) | 12 Months Ended | ||
| Jun. 30, 2022 | Sep. 23, 2022 | Dec. 31, 2021 | |
| Document Information Line Items | |||
| Entity Registrant Name | INMED PHARMACEUTICALS INC. | ||
| Trading Symbol | INM | ||
| Document Type | 10-K/A | ||
| Current Fiscal Year End Date | --06-30 | ||
| Entity Common Stock, Shares Outstanding | 908,761 | ||
| Entity Public Float | $ 18,040,469 | ||
| Amendment Flag | true | ||
| Amendment Description | InMed Pharmaceuticals Inc. (the “Company”) is filing this Amendment No. 1 (“Amendment”) to its Annual Report on Form 10-K for the fiscal year ended June 30, 2022, originally filed with the Securities and Exchange Commission (“SEC”) on September 23, 2022 (the “Original Form 10-K”). The purpose of this Amendment is to (i) include exhibits that were inadvertently omitted from, or incorrectly hyperlinked in, the Original Form 10-K, (ii) disclose the aggregate market value of the Company’s voting and non-voting common equity held by non-affiliates of the Company on the cover page, which disclosure was inadvertently omitted from the cover page of the Original Form 10-K, (iii) correct a typographical error with respect to the year of the Company’s annual meeting of shareholders under “Documents Incorporated by Reference” on the cover page and (iv) provide a new signature page that includes the power of attorney that was inadvertently omitted from the signature page of the Original Form 10-K.Except as described above, no other changes have been made to the Original Form 10-K. The Original Form 10-K continues to speak as of the date of the Original Form 10-K, and the Company has not updated the disclosures contained therein to reflect any events that have occurred as of a date subsequent to the date of the Original Form 10-K. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and the Company’s filings made with the SEC subsequent to the filing of the Original Form 10-K.Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), this Amendment also contains new certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Because no financial statements have been included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K under the Exchange Act, paragraphs 3, 4 and 5 of the certifications have been omitted. | ||
| Entity Central Index Key | 0001728328 | ||
| Entity Current Reporting Status | Yes | ||
| Entity Voluntary Filers | No | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Well-known Seasoned Issuer | No | ||
| Document Period End Date | Jun. 30, 2022 | ||
| Document Fiscal Year Focus | 2022 | ||
| Document Fiscal Period Focus | FY | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | true | ||
| Entity Shell Company | false | ||
| Entity Ex Transition Period | false | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Entity File Number | 001-39685 | ||
| Entity Incorporation, State or Country Code | A1 | ||
| Entity Tax Identification Number | 98-1428279 | ||
| Entity Address, Address Line One | Suite 310 – 815 W Hastings Street | ||
| Entity Address, Address Line Two | Vancouver | ||
| Entity Address, City or Town | B.C | ||
| Entity Address, Country | CA | ||
| Entity Address, Postal Zip Code | V6C 1B4 | ||
| City Area Code | (604) | ||
| Local Phone Number | 669-7207 | ||
| Title of 12(b) Security | Common Shares, no par value | ||
| Security Exchange Name | NASDAQ | ||
| Entity Interactive Data Current | Yes | ||
| Auditor Name | KPMG LLP | ||
| Auditor Location | Vancouver, Canada | ||
| Auditor Firm ID | 85 |
